The placebo controlled randomized double blind multicenter study to investigate effectiveness and safety of combination use of melatonin receptor agonist for dose reduction or interruptions of BZD and non-BZD hypnotics on chronic insomnia.
Phase of Trial: Phase IV
Latest Information Update: 22 Nov 2018
At a glance
- Drugs Ramelteon
- Indications Insomnia
- Focus Therapeutic Use
- 08 Mar 2018 Status changed from not yet recruiting to recruiting.
- 02 Mar 2017 New trial record